Don’t let high cholesterol endanger your heart. We help eligible patients access Repatha (evolocumab) for as little as $69.95 per month through manufacturer Patient Assistance Programs.
The Repatha Prescription Assistance Program is a manufacturer-sponsored initiative that provides Repatha at no medication cost to qualifying patients who cannot afford it. The program is available to uninsured and underinsured U.S. residents who have lived in the U.S. for 6 months or longer and meet income requirements.
Heart disease is the leading cause of death in America, and cholesterol is one of its most modifiable risk factors. When your doctor prescribes Repatha because your LDL cholesterol remains dangerously high despite maximum statin therapy — or because you’ve already had a heart attack or stroke and need aggressive cholesterol lowering — every month without adequate treatment increases your cardiovascular risk.
AffordMyPrescriptions ensures cost never delays the protection you need. For a flat $69.95 per month, our Patient Advocates manage every step of your enrollment, including Medicare Part D pathways.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$239.00 | Save ~$169/mo |
| CVS Pharmacy | ~$239.00 | Save ~$169/mo |
| Walmart | ~$239.00 | Save ~$169/mo |
| Costco | ~$250.00 | Save ~$180/mo |
| Kroger | ~$239.00 | Save ~$169/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
When your cardiologist tells you that your LDL cholesterol is still dangerously high despite maximum statin therapy and that you need a PCSK9 inhibitor to protect your heart, the urgency is real — every week of elevated LDL allows more plaque to accumulate. But accessing Repatha can feel like an obstacle course: insurance prior authorization, step therapy documentation, specialty pharmacy coordination, and copay assistance enrollment.
From the moment you enroll, your advocate takes full ownership of your case. They prepare your application, coordinate with your cardiologist to gather required documentation (statin therapy history, LDL levels, cardiovascular history), submit everything to the appropriate program, and track your status through every stage. When refills are due, they manage that proactively. When annual re-enrollment approaches, they handle it before your coverage expires
Our $69.95/month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment. If we’re unable to secure access to your medication, you won’t be charged.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through Afford My Prescriptions is the better long-term solution:
Specialty pharmacy coordination required
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. The Repatha PAP also typically requires that you have lived in the U.S. for 6 months or longer.
Repatha (evolocumab) is a prescription injectable medication used to lower LDL (“bad”) cholesterol in adults who need additional cholesterol reduction beyond what diet and statins can achieve, to reduce the risk of heart attack, stroke, and cardiovascular death in adults with established cardiovascular disease, and to treat adults and children with familial hypercholesterolemia. Repatha is self-injected at home using a prefilled autoinjector or syringe, typically once every 2 weeks (140 mg) or once monthly (420 mg).
How It Works:
Repatha is a monoclonal antibody that lowers “bad” cholesterol by targeting and blocking the PCSK9 protein. Normally, PCSK9 destroys the liver receptors responsible for clearing cholesterol, but by neutralizing this protein, Repatha allows more receptors to survive. This increases the liver’s ability to filter LDL from the bloodstream, typically resulting in a 50% to 60% reduction in cholesterol levels beyond what statins alone achieve.
Form and Use:
This medication is administered as a subcutaneous injection into the thigh, abdomen, or upper arm using prefilled syringes or SureClick autoinjectors. Depending on the prescribed dose, it is used either every 2 weeks (140 mg) or once monthly (420 mg). It is designed to be used in conjunction with a healthy diet and the highest tolerated dose of statin therapy.
Generic Availability:
There is currently no generic or biosimilar version of Repatha available in the United States as of April 2026. While several biosimilars are currently in development, none have yet received FDA approval. While cash-pay discount options exist for around $239, patients can access the medication for a $69.95 monthly service fee through the AffordMyPrescriptions Patient Assistance Program.
Warnings:
Repatha should not be used by individuals with a known allergy to evolocumab, and patients should notify their doctor regarding pregnancy, breastfeeding, or latex allergies, as some syringes contain natural rubber. Common side effects may include back pain, injection site reactions, and symptoms similar to a common cold. Always consult a healthcare provider to ensure the medication is appropriate for your specific medical history.
The retail price is approximately $500–$689 per month. A cash-pay option through a pharmacy discount partnership brings the price to approximately $239 per month. The manufacturer offers a $25/month copay card for commercially insured patients. Through AffordMyPrescriptions, qualifying patients receive Repatha at no medication cost — our $69.95 monthly fee covers advocacy and program management.
Yes. The Repatha supplied through the Patient Assistance Program is the same FDA-approved evolocumab medication dispensed at retail and specialty pharmacies, supplied directly from the manufacturer.
Not yet. As a biologic, Repatha’s equivalent would be a biosimilar rather than a traditional generic. Several biosimilars are in development but none have received FDA approval as of April 2026.
Yes. Medicare patients may qualify for the Patient Assistance Program. As of 2026, Medicare Part D plans also have a $2,100 annual out-of-pocket cap. Our advocates can help you evaluate the best pathway based on your specific coverage.
Yes. Repatha comes in prefilled autoinjectors or syringes designed for easy self-injection at home. You inject it under the skin in your thigh, abdomen, or upper arm. Your healthcare provider will show you the proper technique. Most patients find it simple after the first few injections
Our Patient Advocates will immediately explore every alternative — including the manufacturer’s $25 copay card, the $239/month cash-pay option, independent co-pay assistance foundations (PAN Foundation, HealthWell), insurance prior authorization appeals, Praluent (alirocumab) as an alternative PCSK9 inhibitor, Leqvio (inclisiran), and combination statin/ezetimibe therapy.
If you are struggling with the high cost of Repatha, our team may be able to help you access assistance programs designed to make medications more affordable. Check your eligibility today and take the first step toward reducing your prescription costs.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.